Navigation Links
Spectral partner launches EAA(TM) Rapid Sepsis Diagnostic in Germany
Date:9/20/2007

TORONTO, Sept. 20 /PRNewswire-FirstCall/ - Spectral Diagnostics Inc. (TSX:SDI) today announced the market launch of its EAA(TM) Endotoxin Activity Assay, a rapid diagnostic product for sepsis, in Germany through A. Menarini Diagnostics Deutschland ("Menarini"), a division of the Italian Menarini Group. Sepsis is the third most common cause of death in Germany with 60,000 victims each year. The treatment of severe sepsis consumes about one third of intensive care units' budgets in Germany ((euro) 1.7 billion per year), emphasizing the need for early detection of sepsis.

"The German launch represents a significant milestone in the commercialization of our EAA(TM) rapid sepsis diagnostic and follows several months of extensive research by our partner Menarini," stated Dr. Paul Walker, President & CEO of Spectral. "Germany is the largest healthcare market in the EU and we are quite confident that with Menarini's broad and experienced sales presence we are well positioned to make a successful entry into this market and set the stage for expansion into the rest of Europe in 2008."

Menarini Diagnostics was founded in 1976 as a division of A. Menarini Industrie Farmaceutiche Riunite of Florence, Italy, a multinational healthcare company with annual revenues of more than 2.2 billion Euros, with eleven wholly owned subsidiaries in Austria, Belgium, France, Germany, Greece, Italy, the Netherlands, Portugal, Spain, United Kingdom and Sweden. Menarini Diagnostics had 2005 consolidated revenues of approximately 256 million Euros and currently employs approximately 700 people, 75% of whom are dedicated to marketing, sales, after-sales service and customer care activities.

Spectral is a developer of innovative technologies for comprehensive disease management. Spectral technologies provide accurate and timely information to clinicians enabling the early initiation of appropriate and targeted therapy. Current products include Spectral's FDA approved rapid di
'/>"/>

SOURCE Spectral Diagnostics Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Jellyfish partners for sales tracking technology
2. GE Healthcare partners with UNC on breast cancer imaging research
3. Manufacturing partnership will move into biotech and biomedical spaces
4. Fergus joins Baird Venture Partners, Caden Bio
5. Avolte Venture Partners reaches capital goal
6. NimbleGen partners with UK biotech firm
7. Big pharma seeks Wisconsin biotech partnerships
8. Thompson in partnership to build ethanol plant
9. Johnson Controls partners on car satellite linkup
10. Doyle, WARF announce partnership to lure stem cell companies
11. GE partner allows real-time access to patient data
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Dallas, Texas (PRWEB) September 23, 2014 ... report on the Global and China Isopropanol (IPA) ... the industry, including definitions, applications and industry chain ... analysis are provided with a focus on history, ... A comparison between the international and Chinese situation ...
(Date:9/23/2014)...   GenoSpace , a precision medicine software company ... enable the broad use of genomic data in research ... awarded Phase I of a Fast Track Small Business ... Health (NIH) to enable enhanced data access and cohort ... During the past decade, the ...
(Date:9/23/2014)... Texas Fertility Center (TFC) announces the opening of ... Central Texas footprint that includes Round Rock, Central Austin, ... the region’s most established practice will provide full service ... Kyle and San Marcos communities. , “We want ... individuals and couples living in and around South Austin,” ...
(Date:9/23/2014)... Dr. Williams says, “Find The Black ... offers a three phase process that can lead to ... that would go far beyond anything previously imagined. First ... of healthcare.” , “Every effort to improve the quality ... discernable progress throughout that system because all of the ...
Breaking Biology Technology:(IPA) Isopropanol Industry International & China Development Trend Analysis Now Available at DeepResearchReports.com 2(IPA) Isopropanol Industry International & China Development Trend Analysis Now Available at DeepResearchReports.com 3GenoSpace Awarded Fast Track SBIR Grant to Enable Data Access and Cohort Construction for Biorepositories 2Opening Doors to a Family: Texas Fertility Center Announces Newest Fertility Clinic in South Austin 2Opening Doors to a Family: Texas Fertility Center Announces Newest Fertility Clinic in South Austin 3Dr. Ira Williams Offers the Healthcare Solution Necessary for Patient Safety Improvement 2
... N.J., May 9 Barr Pharmaceuticals,Inc. (NYSE: ... Laboratories,Inc., has received final approval from the U.S. ... Drug Application (ANDA) to,manufacture and market a generic ... contraceptive product manufactured and marketed,by Bayer Schering Pharma, ...
... May 9 Genaera,Corporation (Nasdaq: GENR ) today announced ... net loss for the quarter ended March 31,2008 was $4.3 ... a net loss of $4.2 million, or $(0.24) per basic ... Genaera,s research and development expenses for the quarter ended March,31, ...
... 9 Schering-Plough,Corporation (NYSE: SGP ) will hold ... Memphis, Tenn. At 8 a.m. (CDT) (9 a.m. EDT) ... be available to all interested,parties via the corporate Web ... Fred Hassan, Chairman and CEO, will report to,shareholders on ...
Cached Biology Technology:Barr Announces Approval of Generic Yasmin(R) 2Barr Announces Approval of Generic Yasmin(R) 3Genaera Corporation Announces First Quarter Financial Results 2Genaera Corporation Announces First Quarter Financial Results 3Genaera Corporation Announces First Quarter Financial Results 4
(Date:9/23/2014)... the effects of temperature on insects to predict how ... a Dartmouth study shows for the first time that ... ultimately limits how fast they grow. , "In other ... overall environmental conditions that shape the growth, survival and ... Lauren Culler , an Arctic postdoctoral researcher at Dartmouth. ...
(Date:9/23/2014)... scientists has identified a gene mutation that causes ... the bone marrow fails to produce normal amounts ... three generations had blood disorders, the researchers discovered ... chromosomal structures with crucial roles in normal cell ... suggest future molecular-based treatments that bypass the gene ...
(Date:9/23/2014)... 23, 2014 Research and Markets  has ... Forecast and Opportunities, 2019" report to their offering. ... for enhancing security and protection in private as well ... The country,s government is focusing on using biometric systems ... other national IDs that are of crucial importance to ...
Breaking Biology News(10 mins):Insects' fear limits boost from climate change, Dartmouth study shows 2Gene mutation discovered in blood disorder 2India Biometrics Market Forecast and Opportunities, 2019 2India Biometrics Market Forecast and Opportunities, 2019 3
... can be swallowed like a pill, injected through a ... to screen for, detect, and potentially treat, cancer and ... size in early development stages. They will also ... researchers at McMaster University will be escalating efforts to ...
... some teenagers taking common anti-depressants may become more aggressive ... the October Behavioral Neuroscience, which is published by the ... of Texas at Austin found that juvenile hamsters given ... the United States as Prozac, became more aggressive on ...
... not be necessary in the event of a large-scale ... a study led by researchers at Fred Hutchinson Cancer ... of Infectious Diseases. , Instead, the current U.S. government ... vaccination of hospital workers and close contacts would be ...
Cached Biology News:Nano-devices hold promise for early-stage cancer detection 2Nano-devices hold promise for early-stage cancer detection 3Adolescent but not adult hamsters are more aggressive on low dose of fluoxetine 2Mass vaccination unnecessary in the event of a large bioterrorist US smallpox attack 2Mass vaccination unnecessary in the event of a large bioterrorist US smallpox attack 3Mass vaccination unnecessary in the event of a large bioterrorist US smallpox attack 4Mass vaccination unnecessary in the event of a large bioterrorist US smallpox attack 5
The Zymo-Spin PI Fast-Spin column features durable polypropylene construction and is the same column featured in the His-Spin Protein Miniprep. Capacity is 800 l....
... Sensitivity Freezing Point Osmometer for 10 ... volume applications, including pediatric, neonatal, geriatric, ... Automatic Calibration with 2 or ... printer, keypad and software for statistical ...
Several Pichia pastoris strains are available to allow you to optimize expression and recovery of your protein of interest. Table 1 provides information to help you choose the appropriate strain....
RayBio Human Atherosclerosis Antibody Array 1.1 (4) with Accessory, detects 40 inflammatory factors (for lysate) Class: Antibody Array Products Product Group: Antibody Array...
Biology Products: